Financials
- Market Capitalization 4.7 M
- Employee 29
- Founded 2017
- CEO N/A
- Website www.bioxceltherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00K20GVD2
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.5
売上高対価格比率
33.08
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4917 | MLEC Moolec Science SA - Ordinary Shares | 6.82 USD | -1.16% | +0.29% | -1.73% | +459.02% | 4.95 M USD | ||
| 4927 | EVGN Evogene Ltd. - Ordinary Shares | 0.55 USD | +5.77% | 0.00% | +12.24% | -56.00% | 4.80 M USD | ||
| 4932 | ADXN Addex Therapeutics Ltd - American Depositary Shares | 3.80 USD | +4.11% | -7.99% | -33.91% | -50.97% | 4.68 M USD | ||
| 4937 | INM InMed Pharmaceuticals Inc. - Common Shares | 1.35 USD | +2.27% | -4.26% | -8.16% | -37.21% | 4.47 M USD |